Dihydropyridine Calcium Channel Blocker [EPC]

248250 reported adverse events

Drugs of this class: NIFEDIPINE FELODIPINE NIMODIPINE NISOLDIPINE ISRADIPINE AMLODIPINE AND VALSARTAN AMLODIPINE AMLODIPINE AND OLMESARTAN MEDOXOMIL CLEVIDIPINE CLEVIPIDINE FELODIPINE EXTENDED-RELEASE TABLETS OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET 40/10/25 MG

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

#	Side effect	Count
0	FATIGUE	13870
1	DYSPNOEA	13371
2	DIARRHOEA	12723
3	NAUSEA	12554
4	DRUG INEFFECTIVE	11505
5	DIZZINESS	10510
6	HEADACHE	9572
7	PAIN	8671
8	ACUTE KIDNEY INJURY	8597
9	OFF LABEL USE	8433

See all common reactions for Dihydropyridine Calcium Channel Blocker [EPC]

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	NON-CARDIOGENIC PULMONARY OEDEMA	235	0.3466
1	GINGIVAL HYPERTROPHY	327	0.3215
2	HYPERPARATHYROIDISM SECONDARY	653	0.2844
3	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	275	0.2823
4	NEPHROGENIC ANAEMIA	1173	0.2711
5	DISTRIBUTIVE SHOCK	224	0.2620
6	VASOPLEGIA SYNDROME	245	0.2549
7	GINGIVAL HYPERPLASIA	150	0.2488
8	BLOOD PRESSURE SYSTOLIC ABNORMAL	290	0.1888
9	BLOOD PRESSURE DIASTOLIC ABNORMAL	317	0.1780

See all enriched reactions for Dihydropyridine Calcium Channel Blocker [EPC]